Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Atherosclerosis. 2015 Sep 5;243(1):38–43. doi: 10.1016/j.atherosclerosis.2015.08.032

Oxidative Stress, Inflammation, and Markers of Cardiovascular Health

Sindhu Lakkur 1,2, Suzanne Judd 2, Roberd M Bostick 1,3,5, William McClellan 3, W Dana Flanders 3,5, Victoria L Stevens 4, Michael Goodman 1,3,5
PMCID: PMC4609620  NIHMSID: NIHMS721395  PMID: 26343870

Abstract

Objective

To investigate associations of a oxidative balance score (OBS) with blood levels of total cholesterol, low-density lipoprotein-(LDL)-cholesterol, high-density lipoprotein-(HDL) cholesterol and triglycerides, and biomarkers of inflammation (serum C-reactive protein [CRP], albumin and venous total white blood cell [WBC] counts) among 19,825 participants in a nationwide study.

Methods

Using cross-sectional data 14 dietary and lifestyle components were incorporated into the OBS and the resulting score (range 3–26) was then divided into five equal intervals. Multivariable-adjusted odds ratios (ORs) for abnormal biomarker levels and 95% confidence intervals (CIs) were calculated using logistic regression models.

Results

The ORs (95% CIs) comparing those in the highest relative to those in the lowest OBS equal interval categories were 0.50 (0.38–0.66) for CRP, 0.50 (0.36–0.71) for the total WBC count, and 0.75 (0.58–0.98) for LDL-cholesterol; all three p-values for trend were <0.001. The OBS-HDL-cholesterol association was statistically significantly inverse among females, but not among males. The OBS was not associated with serum albumin or triglycerides.

Conclusion

Our findings suggest that an OBS may be associated with some, but not all, circulating lipids/lipoproteins and biomarkers of inflammation.

Keywords: Epidemiology, Oxidative stress, Inflammation, Lipoproteins

Introduction

Oxidative stress is an imbalance between pro-oxidants and antioxidants, which results in macromolecular damage and disruption of redox signaling and control.1 It is a complex physiological process, closely interrelated with inflammation.2

Several exogenous factors may act as pro-oxidants by increasing levels of reactive oxygen species (ROS). ROS are present in the tar and smoke of cigarettes, and smoking also produces a secondary release of ROS from inflammatory cells.3 Another important pro-oxidant is iron, which is consumed along with heme in large quantities as part of a red meat-rich diet. Iron may increase oxidative stress by catalyzing the production of highly reactive hydroxyl radicals via the Haber-Weiss reaction.4 Alcohol induces oxidative stress through its metabolism, by inhibiting antioxidant enzymes, and by causing inflammation.5

In-vitro evidence indicates that the effects of ROS and oxidative stress-induced inflammation can be reversed by certain antioxidant nutrients.6 Carotenoids, lutein, lycopene, vitamin C, vitamin E, and flavonoids, can protect against lipid peroxidation and terminate free radical chain reactions.7 Selenium and manganese are critical components of antioxidant enzymes.7 Other nutrients can also indirectly contribute to a reduction in ROS. Omega-3 fatty acids contribute to oxidative stress through peroxidation8, but also induce electrophile-responsive element (EpRE), which regulates genes responsible for transcribing antioxidant enzymes.9 Moreover, omega-3 fatty acids have anti-inflammatory properties and therefore indirectly decrease oxidative stress.10

Although oxidative stress and inflammation are implicated in the pathogenesis of numerous diseases,2, 11 and antioxidants slow down these processes in-vitro6, clinical trials of antioxidants as disease prevention agents have produced null or adverse results.12, 13 Other studies of chronic diseases found that a combination of factors may be more strongly associated with disease risk than any nutrient considered individually.14, 15 This led to a hypothesis that a combination of pro-oxidant and antioxidant exposures incorporated into a composite measure of oxidative balance may be more strongly associated with health outcomes more than would any one factor considered individually.16, 17

To address this issue we, and others, proposed using an oxidative balance score (OBS), an overall measure of oxidative stress-related exposures based on the summed intakes of various pro- and anti-oxidants, with a higher score indicating lower oxidative stress.16, 17 Previous studies found that a higher OBS was associated with lower risk of colorectal adenoma16, 18 and mortality,17 but not prostate cancer,19 indicating that the role of oxidative stress in human pathophysiology may be organ- or disease-specific. To better understand the specific roles of oxidative stress-modifying exposures in various health outcomes, the potential mechanisms represented by an OBS should be examined using biomarkers, which can act as upstream indicators of future health events.20

We examined associations between an OBS and circulating biomarkers of inflammation including C-reactive protein (CRP), albumin, and total white blood cell (WBC) count. Previous epidemiological studies have used WBC count as a marker of inflammation.21 In its 2003 scientific statement, the American Heart Association (AHA) classified WBC count as an inflammatory marker.22 Hypoalbuminemia serves as a marker of inflammation because chronic inflammation has been shown to reduce rate of albumin synthesis.23 CRP, an acute-phase reactant, is a reliable biomarker of inflammation24 that has been shown to increase in the presence of oxidative stress.25 We also assessed the association between OBS and blood levels of lipids/lipoproteins including total, LDL-, and HDL-cholesterol, and triglycerides. We examined these associations in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study cohort, with the hypothesis that a beneficial balance of pro-/anti-oxidants will be inversely related to abnormal biomarker levels.

Materials and Methods

Study Population

The REGARDS prospective cohort study is designed to examine the causes of racial and geographic disparities in stroke, and offers an opportunity for ancillary research projects. The cohort is comprised of 30,239 black and white males and females, ages 45 or older, enrolled from January 2003 to October 2007. The institutional review boards of the multiple participating entities approved this study. Participants were recruited by telephone and mail from 1,842 (59%) of 3,140 US counties, with an oversampling of blacks and residents of the Stroke Belt (noncoastal regions of Alabama, Arkansas, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, and Tennessee) and Stroke Buckle (coastal plain regions of North Carolina, South Carolina, and Georgia), and the remainder of the rest of the continental US. At baseline, an interview was conducted by telephone to obtain demographic and risk factor information, and blood samples and physical measurements were obtained during an in-home visit. A self-administered questionnaire food frequency questionnaire (FFQ) was left with the participant to be returned by self-addressed prepaid envelopes. Details of the study design can be found elsewhere.26

Laboratory Analyses

After an overnight fast, blood samples were drawn, centrifuged, and then shipped to the University of Vermont central laboratory for reprocessing and analysis. Plasma CRP was measured using particle-enhanced immunonephelometry (N High-Sensitivity CRP assay; Dade Behring, Inc., Deerfield, Illinois).27 Venous total WBC counts were measured using an automated analyzer (Beckman Coulter, Inc., Fullerton, California).28 Serum total and HDL-cholesterol, triglycerides, and albumin were measured by colorimetric reflectance spectrophotometry using the Ortho Vitros Clinical Chemistry System 950IRC instrument (Johnson & Johnson Clinical Diagnostics). Serum LDL-cholesterol concentrations were determined using the Friedewald equation.29

Definitions

Elevated CRP was defined as >3 mg/L.22 Hypoalbuminemia was defined as <3.5g/dL.30 Cutoffs for lipid biomarkers were defined using the National Cholesterol Education Program’s (NCEP) Adult Treatment Panel III Guidelines (elevated total cholesterol: ≥ 200 mg/dL, elevated LDL: >100 mg/dL, elevated triglycerides: ≥150 mg/dL, and low HDL for males and females: <40 mg/dL).31 Elevated total WBC count was defined as being above the 75th percentile (>6.86 × 109 cells/L).32

Covariates included age, sex, total energy intake, BMI, self-reported race (black or white), educational level (college graduate or higher, some college, high school graduate or GED, or less than high school), region (Stroke Buckle, rest of the Stroke Belt, or other), and frequency of physical activity (≥4 times/week, 1–3 times/week, or none).

OBS components and their assessment

The OBS was comprised of 14 components that were selected based on a priori knowledge about their relation to oxidative stress. Dietary components were derived from the self-administered 98-item Block FFQ.33 Nutrient contents of foods were determined using the Block nutrient database with composition values from the U.S. Department of Agriculture and other sources.34 The nutrient intakes were calculated by multiplying the reported frequency of consumption by the nutrient composition of the specified portion size for each food item. Nutrient values in this analysis represent the total dietary and supplemental intake for each nutrient.

The components of the OBS are summarized in Supplementary Table 1 and calculation of the OBS is available in Supplementary Methods. Briefly, the points assigned to each OBS component were summed to create the overall OBS, which was divided into equal interval categories. The cut points for the categories were determined using the distribution of the OBS within the analysis cohort, and are listed in Table 2. A high OBS indicates a presumably beneficial balance of pro- and anti-oxidants.

Table 2.

Associations between the Oxidative Balance Score and biomarkers of inflammation in the REGARDS cohort

Biomarker LS mean (SD) Normal
biomarker
levels (n)
Abnormal
biomarker
levels (n)
OR (95% CI)d p-trende
Elevated serum CRPa

  OBS Interval
    3–7 5.73 (7.75) 454 383 1.0 <0.01
    8–12 5.05 (8.16) 3,414 2,504 0.77 (0.66 – 0.90)
    13–17 4.44 (8.57) 5,370 3,274 0.62 (0.53 – 0.72)
    18–21 4.15 (8.31) 2,338 1,255 0.53 (0.45 – 0.62)
    22–26 3.88 (7.71) 236 123 0.50 (0.38 – 0.66)

Elevated total WBC countb

  OBS Interval
    3–7 6.38 (3.01) 377 214 1.0 <0.01
    8–12 6.05 (3.19) 3,051 1,148 0.63 (0.53 – 0.76)
    13–17 5.83 (3.39) 4,688 1,431 0.51 (0.43 – 0.61)
    18–21 5.80 (3.26) 1,992 558 0.46 (0.38 – 0.56)
    22–26 5.69 (3.00) 196 61 0.50 (0.36 – 0.71)

Low serum albuminc

  OBS Interval
    3–7 4.15 (0.32) 612 7 1.0 0.65
    8–12 4.16 (0.33) 4,379 69 1.23 (0.56 – 2.71)
    13–17 4.19 (0.35) 6,377 70 0.87 (0.39 – 1.92)
    18–21 4.19 (0.34) 2,653 37 1.08 (0.47 – 2.50)
    22–26 4.16 (0.31) 266 5 1.44 (0.44 – 4.67)
a

CRP cutoffs: normal CRP, ≤3.0 mg/L (n=11,812); high CRP, >3.0 mg/L (n=7,539)

b

WBC count cutoffs: normal WBC count, ≤6.86 × 109 cells/L (n=10,304); high WBC count, >6.86×109 cells/L (n=3,412)

c

Albumin cutoffs: normal albumin, >=3.5 g/dL (n=14,287); hypoalbuminemia, <3.5 g/dL (n=188)

d

Adjusted for age, sex, race, BMI, total daily energy, education, region, and exercise.

e

X2 test

Statistical Analysis

In descriptive analyses, the means, standard deviations, and frequencies were calculated for covariates and biomarker measurements within each OBS interval. To assess differences in various parameters across OBS intervals, the chi-square test was used for categorical variables and analysis of variance (ANOVA) was used for continuous variables. With the exception of serum albumin, the biomarker measurements were not normally distributed, and so were log transformed when used in linear regression analyses. Multivariable linear regression models were constructed to assess associations between the OBS and each biomarker expressed as a continuous measure. To calculate the standardized linear regression coefficients, the biomarker variables were standardized, so that their variances were equal to one.

Multivariable logistic regression models were used to examine the association of OBS with abnormal biomarker levels. The results were expressed as adjusted odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) adjusted for age, sex, total energy intake, BMI, race, educational level, region, and physical activity. The potential confounders were selected based on evidence in the literature and other a priori considerations. All models were examined for collinearity among independent variables and for interaction between the OBS and each covariate. When a statistically significant interaction was found, a stratified analysis was conducted to determine whether the OBS-biomarker association was appreciably modified by the covariate. Sensitivity analyses were conducted to examine the impact of individual OBS components by removing each OBS component from the score and controlling for it as a covariate and evaluate the impacts of different OBS categorization approaches (5 equal intervals, 4 equal intervals, or quartiles) and different outcome definitions on the results. We examined the results for low HDL using cutoffs from the American Heart Association’s guidelines for cardiovascular disease prevention (<50 mg/dL in females and <40 mg/dL in males).22 All analyses were conducted using SAS statistical software version 9.2 (SAS institute, Cary North Carolina).

Results

Seventy-two percent of participants (n=21,636) returned the completed FFQ. Individuals were excluded if no biomarker measurements were recorded (n =770), OBS components were missing (n = 433), or if they had a body mass index (BMI) of < 18.5 kg/m2 (n = 336) or incomplete covariate information (n = 272). This resulted in an analytical cohort of 19,825 participants with at least one biomarker measurement. The number of participants with measurements for individual biomarkers varied as follows: 19,531 for serum CRP; 19,790 for serum total cholesterol, 19,685 for HDL-cholesterol, 19,416 for LDL-cholesterol, 19,782 for serum triglycerides,14,475 for serum albumin, and 13,716 for total venous WBC count. Albumin and WBC count were measured only in a subset of participants (n = 21,658) who were enrolled in an ancillary study.28

The characteristics of participants in the analysis cohort are presented by equal interval OBS categories in Table 1. Compared to those in the lowest OBS interval (range 3–7), participants in the highest OBS interval (range 22–26) were older and had a higher energy intake. The proportion of participants who were female, Caucasian, college educated, exercised ≥4 times/week, and resided outside the stroke belt increased with increasing OBS. There was no significant difference in BMI across OBS intervals.

Table 1.

REGARDS (2003–2007) cohort characteristics and biomarker measurements by Oxidative Balance Score categories

Covariates Equal-interval OBS categories

3–7
(n=861)
8–12
(n=6,050)
13–17
(n=8,862)
18–21
(n=3,682)
22–26
(n=370)
P-
value
Age (yrs.), Mean (SD) 61 (8.9) 64 (9.2) 65 (9.2) 66 (9.1) 67 (8.6) <0.01
Male, (%) 416 (48.3) 2,789 (46.1) 3,901 (44.0) 1,581 (42.9) 142 (38.4) <0.01
Caucasian, (%) 555 (64.5) 3937 (65.1) 5,957 (67.2) 2,543 (69.8) 271 (73.2) <0.01
Education, (%) <0.01
  College education or higher 212 (24.6) 1,942 (32.1) 3,489 (39.4) 1,647 (44.7) 178 (48.1)
  Some college 269 (31.2) 1,682 (27.8) 2,402 (27.1) 989 (26.9) 92 (24.9)
  High school graduate 275 (31.9) 1,731 (28.6) 2,187 (24.7) 787 (21.4) 82 (22.2)
  Less than high school 105 (12.3) 695 (11.5) 784 (8.8) 259 (7.0) 18 (4.8)
Geographical region, (%) <0.01
  Stroke Belt 327 (38.0) 2,187 (36.2) 3,014 (34.0) 1,199 (32.6) 125 (33.8)
  Stroke Buckle 181 (21.0) 1,413 (23.4) 1,921 (21.7) 763 (20.7) 68 (18.4)
  Other 3,353 (41.0) 2,450 (40.4) 3,927 (44.3) 1,720 (46.7) 177 (47.8)
Exercise, (%) <0.01
  ≥4 times/week 206 (23.9) 1,655 (27.4) 2,780 (31.4) 1,299 (35.3) 131 (35.4)
  1–3 times/week 301 (35.0) 2,150 (35.5) 3,390 (38.3) 1,365 (37.1) 133 (36.0)
  None 354 (41.1) 2,245 (37.1) 2,692 (30.3) 1,018 (27.6) 106 (28.6)
Total energy intake (kcal/day), Mean (SD) 1,444 (560) 1,508 (624) 1,751 (705) 1,977 (768) 1,915 (644) <0.01
BMI (kg/m2), Mean (SD) 28.1 (5.5) 29.2 (6.0) 29.2 (5.9) 29.3 (6.0) 29.4 (6.4) <0.01

Population: any participant with at least one biomarker (n=19,825).

Analysis for biomarker limited to participants on whom the biomarker was measured: CRP, n=19,531; total cholesterol, n=19,790; HDL, n=19,685; LDL, n=19,416; triglycerides, n=19,782; albumin, n=14,475; WBC count, n=13,716.

Values presented as mean (SD) or number (%).

Associations of the OBS with each of the biomarkers expressed a continuous variables, are shown in Supplementary Table 2. The results for HDL are presented separately for males and females because there was a statistically significant (p<0.01) OBS-sex interaction. The associations were in the hypothesized direction for CRP, total cholesterol, HDL (among females), LDL, triglycerides, albumin, and WBC count. Only the associations for CRP, total cholesterol, LDL, triglycerides, serum albumin, WBC, and HDL among females were statistically significant. The standardized regression coefficients indicate that among all the biomarkers, OBS was most strongly associated with CRP and WBC.

The odds of an elevated CRP or WBC count were 50% lower for participants in the highest versus the lowest OBS with evidence of a statistically significant inverse dose-response relationship (both ptrend <0.01),. None of the OBS interval-specific ORs for low albumin was statistically significant and there was no evidence of a dose-response association (Table 2).

As shown in Table 3, for total cholesterol, the ORs (95% CIs) comparing those in the second through fifth OBS intervals to those in the lowest (first) interval were all approximately 15% lower, with the test for trend and the estimates for the third and fourth intervals being statistically significant, whereas the essentially same magnitude estimate in the upper interval (in which there were fewer persons) was not. The corresponding analyses for LDL similarly revealed a statistically significant inverse trend and statistically significant 25% lower odds of an elevated LDL among those in the highest versus those in the lowest OBS interval. None of the OBS interval-specific ORs for elevated triglycerides were statistically significant and there was no evidence of a dose-response relationship.

Table 3.

Associations between the Oxidative Balance Score and lipids/lipoproteins in the REGARDS cohort

Biomarker LS mean (SD) Normal
biomarker
levels (n)
Abnormal
biomarker
levels (n)
OR (95% CI)d p-
trende
Elevated serum total cholesterola

  OBS Interval
    3–7 194 (39) 482 376 1.0 0.05
    8–12 192 (41) 3,622 2,422 0.89 (0.77 – 1.03)
    13–17 190 (43) 5,359 3,485 0.85 (0.74 – 0.99)
    18–21 190 (41) 2,232 1,442 0.84 (0.72 – 0.99)
    22–26 189 (38) 223 147 0.85 (0.66 – 1.10)

Elevated serum LDL-cholesterolb

  OBS Interval
    3–7 116 (34) 263 585 1.0 <0.01
    8–12 114 (36) 2,113 3,817 0.85 (0.73 – 0.99)
    13–17 113 (38) 3,204 5,465 0.80 (0.69 – 0.93)
    18–21 113 (36) 1,387 2,218 0.75 (0.64 – 0.89)
    22–26 112 (34) 141 223 0.75 (0.58 – 0.98)

Elevated serum triglyceridesc

  OBS Interval
    3–7 130 (88) 613 345 1.0 0.17
    8–12 129 (87) 4,229 1,811 1.05 (0.89 – 1.23)
    13–17 129 (92) 6,344 2,496 0.98 (0.83 – 1.15)
    18–21 128 (90) 2,630 1,044 0.99 (0.83 – 1.18)
    22–26 132 (83) 255 115 1.11 (0.84 – 1.47)
a

Cholesterol cutoffs: normal cholesterol, <200 mg/dL (n=11,918); High cholesterol, ≥200 mg/dL (n=7,872)

b

LDL cutoffs: normal LDL, <100mg/dL (n=7,108); high LDL, ≥100 mg/dL (n=12,308)

c

Triglycerides cutoffs: normal triglycerides, < 150 mg/dL (n=14,071); high triglycerides, ≥150 mg/dL (n=5,711)

d

Adjusted for age, sex, race, BMI, total daily energy, education, region, and exercise

e

X2 test

In the analyses for low vs. normal HDL (Table 4) there was again a statistically significant interaction between OBS and sex (p<0.01); these analyses are presented separately for males and females. Using the NCEP definition, the odds of a low HDL were 63% higher among males (OR=1.63; 95% CI: 1.09–2.45; p-trend = 0.13) but 52% lower among females (OR=0.48; 95% CI: 0.28–0.83; p-trend = 0.05) in the highest versus the lowest OBS category. No significant differences in the observed associations for the other biomarkers when stratified by race or sex (data not shown).

Table 4.

Associations between the Oxidative Balance Score and serum HDL-cholesterol levela by sex in the REGARDS cohort

Sex LS Mean (SD) Normal HDL Low HDL OR (95% CI)d p-trende
Femaleb

  OBS Interval
    3–7 55.49 (0.75) 380 62 1.0 0.05
    8–12 57.12 (0.29) 2,872 364 0.71 (0.53 – 0.95)
    13–17 57.57 (0.24) 4,376 538 0.72 (0.54 – 0.96)
    18–21 57.59 (0.36) 1,862 214 0.68 (0.50 – 0.93)
    22–26 57.54 (1.04) 209 19 0.48 (0.28 – 0.83)

Malec

  OBS Interval
    3–7 47.06 (0.64) 277 136 1.0 0.13
    8–12 45.99 (0.27) 1,725 1,050 1.22 (0.97 – 1.53)
    13–17 45.65 (0.24) 2,420 1,464 1.25 (1.00 – 1.56)
    18–21 45.56 (0.36) 997 579 1.22 (0.96 – 1.55)
    22–26 45.10 (1.09) 83 58 1.63 (1.09 – 2.45)
a

Normal HDL (≥40 mg/dL); Low HDL (<40 mg/dL)

b

Normal HDL (n=9,699); Low HDL (n=1,197)

c

Normal HDL (n=5,502); Low HDL (n=3,287)

d

Adjusted for age, race, BMI, total daily energy, education, region, and exercise

e

X2 test

Sensitivity analyses found that removing an OBS component resulted in OR estimates within 5% of the original model result (data not shown). Multiple categorizations of OBS, results using quartiles or 4 equal interval categories of OBS were essentially the same for all biomarkers. The only exception was HDL, where the interaction with sex was no longer statistically significant. More robust results for albumin were observed using four equal interval categories due to the low number of participants with hypoalbuminemia, but 5 equal intervals were used for consistency. Under the AHA guidelines, which had a higher low HDL cutoff for females, the OBS-HDL association among females was also inverse and most pronounced when comparing those in the highest to those in the lowest OBS interval (OR=0.65; 95% CI: 0.46 – 0.92; p-trend < 0.01).

Discussion

The idea that a score may be more strongly associated with health-related outcomes than are individual factors is well accepted in nutrition research.35 In the ATTICA study, a Mediterranean diet score was calculated by assigning higher points to frequent consumption of food items adhering to the pattern and lower points to items not adhering to it. Participants in the highest tertile of total adherence had 20% lower CRP levels and 14% lower total white blood cell counts, relative to those in the lowest tertile of adherence.21 A separate analysis from the ATTICA study also found a statistically significant inverse association between adherence to the Mediterranean diet and serum total cholesterol.36

Other studies have examined associations between an OBS and biomarkers of oxidative stress and inflammation, and observed a similar inverse associations between OBS and inflammatory markers such as CRP and F2-isoprostanes.3739 This indicates that low OBS is associated with low-grade inflammation, which has a role in the pathobiology of obesity and metabolic syndrome.40 We found that sex modified the association between the OBS and low serum HDL. On average, females have higher HDL levels than males.31 Environmental factors may explain some, but not all, of this sex difference.41 Several studies found that an association between smoking and HDL level is greater among females than among males.4143 Possible mechanisms are not well understood, but may include sex differences in lipid metabolism and the antiestrogenic effect of cigarette smoking.43 In an analysis of a population from six different countries smoking was associated with lower HDL levels among females (−0.15 mmol/L) than among males (−0.05 mmol/L).41 Similarly, in the Framingham Offspring Study, compared to non-smokers of the same sex, female smokers had a significantly lower HDL level than did male smokers.44 We also found that the magnitude of the association between smoking and low HDL was greater among females than males. However, analyses assessing the association between each individual component and low HDL indicated that no single factor could fully explain the interaction between OBS and sex (data not shown). At this time, there is only epidemiological evidence supporting our findings on effect modification by sex. Basic science/clinical studies can be conducted to elucidate mechanistic explanations.

One of the strengths of the present study was the ability to incorporate both dietary and lifestyle components into the score, allowing a more comprehensive view of various determinants of oxidative stress.45 Besides demographic diversity, there was substantial variability in the intake of dietary components, which allowed us to compare extremes of the OBS.

A limitation of this study was the lack of information about genotypes that may influence the metabolism of OBS components. For example, polymorphisms modify the association between alcohol consumption and HDL level.46 We did not have information on infection status of participants, and it is possible that the inverse association between OBS and inflammatory markers could be attributed to unmeasured confounding. However, this is unlikely, as a number of studies in different populations have observed similar associations.38, 47

We measured OBS components based on FFQs, a dietary assessment method that has known limitations.48 OBS, measured by FFQs, has been used in a number of peer-reviewed publications.16, 17, 19, 39 Similar associations were observed when OBS was measured by replacing questionnaire responses with biomarkers of pro- and antioxidant exposures.37

Oxidative stress is a complex and multifactorial process that is influenced by a number of modifiable pro- and anti-oxidant factors. The purpose of OBS is to examine the balance of these modifiable factors; this approach has been used in a number of previous publications.16, 17, 19, 39 In addition to extrinsic modifiable factors, oxidative stress is also influenced by intrinsic factors such as antioxidant enzymes and cellular energy balance;49 These factors are not included in the OBS. Further, oxidative stress itself can be measured using a variety of biomarkers. These biomarkers serve as in vivo measures of redox signaling and oxidation of macromolecules. Individual biomarkers of oxidative stress may reflect different aspects of this process, and for this reason, several studies explored combining various measures in a single score.50

In summary, we found that OBS was statistically significantly associated with several, but not all of the circulating markers of inflammation and lipids/lipoproteins that we measured. The association between the OBS and serum HDL-cholesterol substantially differed by sex, an observation that requires confirmation, and if confirmed, exploration of the underlying mechanism(s). Our study’s cross-sectional design cannot establish mechanisms, but can generate hypotheses and may help stimulate future research. Our findings provide further support for studying oxidative stress-related dietary and lifestyle factors in combination, rather than as individual exposures. This study implies that clinical interventions to improve biomarker levels should focus on multiple extrinsic sources of oxidative stress, rather than any individual source.

Supplementary Material

Highlights.

  • Associations of oxidative balance score (OBS) with lipids/lipoproteins, and inflammatory biomarkers were investigated in a nationwide study

  • High OBS indicates a presumably beneficial balance of pro- and anti-oxidants

  • In the analyses of inflammatory biomarkers, OBS was inversely associated with high CRP and total WBC counts, but not low albumin

  • For lipids/lipoproteins, an inverse association was found with high LDL, total cholesterol, but not high triglycerides

  • Sex modified the association between OBS and low HDL

Acknowledgments

Funding Sources

This research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data.2 The authors thank the other investigators, the staff, and the participants of the REGARDS study for their valuable contributions. S. Lakkur was supported by a training grant from the National Heart, Lung, and Blood Institute (grant T32HL072757).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Disclosures

A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org.

References

  • 1.Sies H, Jones D. Oxidative stress. Encyclopedia of Stress. 2007:45–48. [Google Scholar]
  • 2.Bondia-Pons I, Ryan L, Martinez JA. Oxidative stress and inflammation interactions in human obesity. Journal of physiology and biochemistry. 2012;68:701–711. doi: 10.1007/s13105-012-0154-2. [DOI] [PubMed] [Google Scholar]
  • 3.van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax. 2004;59:713–721. doi: 10.1136/thx.2003.012468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Swain JH, Alekel DL, Dent SB, Peterson CT, Reddy MB. Iron indexes and total antioxidant status in response to soy protein intake in perimenopausal women. Am J Clin Nutr. 2002;76:165–171. doi: 10.1093/ajcn/76.1.165. [DOI] [PubMed] [Google Scholar]
  • 5.Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism. 2003;27:277–284. [PMC free article] [PubMed] [Google Scholar]
  • 6.Stahl W, Sies H. Antioxidant activity of carotenoids. Molecular aspects of medicine. 2003;24:345–351. doi: 10.1016/s0098-2997(03)00030-x. [DOI] [PubMed] [Google Scholar]
  • 7.Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-biological interactions. 2006;160:1–40. doi: 10.1016/j.cbi.2005.12.009. [DOI] [PubMed] [Google Scholar]
  • 8.Friedman A, Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol. 2006;1:182–192. doi: 10.2215/CJN.00740805. [DOI] [PubMed] [Google Scholar]
  • 9.van Beelen VA, Aarts JM, Reus A, Mooibroek H, Sijtsma L, Bosch D, et al. Differential induction of electrophile-responsive element-regulated genes by n-3 and n-6 polyunsaturated fatty acids. FEBS letters. 2006;580:4587–4590. doi: 10.1016/j.febslet.2006.07.028. [DOI] [PubMed] [Google Scholar]
  • 10.Calder PC. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:1505S–1519S. doi: 10.1093/ajcn/83.6.1505S. [DOI] [PubMed] [Google Scholar]
  • 11.Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free radical biology & medicine. 2010;49:1603–1616. doi: 10.1016/j.freeradbiomed.2010.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Goodman M, Bostick RM, Kucuk O, Jones DP. Clinical trials of antioxidants as cancer prevention agents: Past, present, and future. Free radical biology & medicine. 2011;51:1068–1084. doi: 10.1016/j.freeradbiomed.2011.05.018. [DOI] [PubMed] [Google Scholar]
  • 13.Steinhubl SR. Why have antioxidants failed in clinical trials? The American journal of cardiology. 2008;101:14D–19D. doi: 10.1016/j.amjcard.2008.02.003. [DOI] [PubMed] [Google Scholar]
  • 14.Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN. Eating patterns and risk of colon cancer. American journal of epidemiology. 1998;148:4–16. doi: 10.1093/aje/148.1.4-a. [DOI] [PubMed] [Google Scholar]
  • 15.Huijbregts P, Feskens E, Rasanen L, Fidanza F, Nissinen A, Menotti A, et al. Dietary pattern and 20 year mortality in elderly men in finland, italy, and the netherlands: Longitudinal cohort study. BMJ. 1997;315:13–17. doi: 10.1136/bmj.315.7099.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Goodman M, Bostick RM, Dash C, Terry P, Flanders WD, Mandel J. A summary measure of pro- and anti-oxidant exposures and risk of incident, sporadic, colorectal adenomas. Cancer causes & control : CCC. 2008;19:1051–1064. doi: 10.1007/s10552-008-9169-y. [DOI] [PubMed] [Google Scholar]
  • 17.Van Hoydonck PG, Temme EH, Schouten EG. A dietary oxidative balance score of vitamin c, beta-carotene and iron intakes and mortality risk in male smoking belgians. The Journal of nutrition. 2002;132:756–761. doi: 10.1093/jn/132.4.756. [DOI] [PubMed] [Google Scholar]
  • 18.Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Gnardellis C, Lagiou P, Polychronopoulos E, et al. Diet and overall survival in elderly people. BMJ. 1995;311:1457–1460. doi: 10.1136/bmj.311.7018.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lakkur S, Goodman M, Bostick RM, Citronberg J, McClellan W, Flanders WD, et al. Oxidative balance score and risk for incident prostate cancer in a prospective u.S. Cohort study. Annals of epidemiology. 2014;24:475–478. e474. doi: 10.1016/j.annepidem.2014.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Vasan RS. Biomarkers of cardiovascular disease: Molecular basis and practical considerations. Circulation. 2006;113:2335–2362. doi: 10.1161/CIRCULATIONAHA.104.482570. [DOI] [PubMed] [Google Scholar]
  • 21.Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the mediterranean diet attenuates inflammation and coagulation process in healthy adults: The attica study. J Am Coll Cardiol. 2004;44:152–158. doi: 10.1016/j.jacc.2004.03.039. [DOI] [PubMed] [Google Scholar]
  • 22.Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Circulation. 2003;107:499–511. doi: 10.1161/01.cir.0000052939.59093.45. [DOI] [PubMed] [Google Scholar]
  • 23.Don BR, Kaysen G. Serum albumin: Relationship to inflammation and nutrition. Seminars in dialysis. 2004;17:432–437. doi: 10.1111/j.0894-0959.2004.17603.x. [DOI] [PubMed] [Google Scholar]
  • 24.Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atherosclerosis. Supplements. 2005;6:21–29. doi: 10.1016/j.atherosclerosissup.2005.02.005. [DOI] [PubMed] [Google Scholar]
  • 25.Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, et al. Factors associated with oxidative stress in human populations. American journal of epidemiology. 2002;156:274–285. doi: 10.1093/aje/kwf029. [DOI] [PubMed] [Google Scholar]
  • 26.Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, et al. The reasons for geographic and racial differences in stroke study: Objectives and design. Neuroepidemiology. 2005;25:135–143. doi: 10.1159/000086678. [DOI] [PubMed] [Google Scholar]
  • 27.Cushman M, McClure LA, Howard VJ, Jenny NS, Lakoski SG, Howard G. Implications of increased c-reactive protein for cardiovascular risk stratification in black and white men and women in the us. Clinical chemistry. 2009;55:1627–1636. doi: 10.1373/clinchem.2008.122093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zakai NA, McClure LA, Prineas R, Howard G, McClellan W, Holmes CE, et al. Correlates of anemia in american blacks and whites: The regards renal ancillary study. American journal of epidemiology. 2009;169:355–364. doi: 10.1093/aje/kwn355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Aaron KJ, Campbell RC, Judd SE, Sanders PW, Muntner P. Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the reasons for geographic and racial differences in stroke (regards) study. Am J Clin Nutr. 2011;94:1071–1078. doi: 10.3945/ajcn.111.013094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutrition journal. 2010;9:69. doi: 10.1186/1475-2891-9-69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) JAMA : the journal of the American Medical Association. 2001;285:2486–2497. doi: 10.1001/jama.285.19.2486. [DOI] [PubMed] [Google Scholar]
  • 32.Kabagambe EK, Judd SE, Howard VJ, Zakai NA, Jenny NS, Hsieh M, et al. Inflammation biomarkers and risk of all-cause mortality in the reasons for geographic and racial differences in stroke cohort. American journal of epidemiology. 2011;174:284–292. doi: 10.1093/aje/kwr085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. American journal of epidemiology. 1986;124:453–469. doi: 10.1093/oxfordjournals.aje.a114416. [DOI] [PubMed] [Google Scholar]
  • 34.United states department of agriculture: Nutrient database for standard reference [releases 10 and 11] [Google Scholar]
  • 35.Hu FB. Dietary pattern analysis: A new direction in nutritional epidemiology. Current opinion in lipidology. 2002;13:3–9. doi: 10.1097/00041433-200202000-00002. [DOI] [PubMed] [Google Scholar]
  • 36.Panagiotakos DB, Pitsavos C, Stefanadis C. Dietary patterns: A mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2006;16:559–568. doi: 10.1016/j.numecd.2005.08.006. [DOI] [PubMed] [Google Scholar]
  • 37.KONG SJ, Bostick R, Flanders WD, McClellan WM, Thyagarajan B, Gross MD, et al. Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation. Cancer Epidemiology Biomarkers & Prevention. 2014 doi: 10.1158/1055-9965.EPI-13-0619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lakkur S, Bostick RM, Roblin D, Ndirangu M, Okosun I, Annor F, et al. Oxidative balance score and oxidative stress biomarkers in a study of whites, african americans, and african immigrants. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2014:1–10. doi: 10.3109/1354750X.2014.937361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Dash C, Goodman M, Flanders WD, Mink PJ, McCullough ML, Bostick RM. Using pathway-specific comprehensive exposure scores in epidemiology: Application to oxidative balance in a pooled case-control study of incident, sporadic colorectal adenomas. American journal of epidemiology. 2013;178:610–624. doi: 10.1093/aje/kwt007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Das UN. Obesity, metabolic syndrome x, and inflammation. Nutrition. 2002;18:430–432. doi: 10.1016/s0899-9007(01)00747-x. [DOI] [PubMed] [Google Scholar]
  • 41.Davis CE, Williams DH, Oganov RG, Tao SC, Rywik SL, Stein Y, et al. Sex difference in high density lipoprotein cholesterol in six countries. American journal of epidemiology. 1996;143:1100–1106. doi: 10.1093/oxfordjournals.aje.a008686. [DOI] [PubMed] [Google Scholar]
  • 42.Taylor KG, Carter TJ, Valente AJ, Wright AD, Smith JH, Matthews KA. Sex differences in the relationships between obesity, alcohol consumption and cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population. Atherosclerosis. 1981;38:11–18. doi: 10.1016/0021-9150(81)90098-8. [DOI] [PubMed] [Google Scholar]
  • 43.Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the finnmark study. Circulation. 1996;93:450–456. doi: 10.1161/01.cir.93.3.450. [DOI] [PubMed] [Google Scholar]
  • 44.Garrison RJ, Kannel WB, Feinleib M, Castelli WP, McNamara PM, Padgett SJ. Cigarette smoking and hdl cholesterol: The framingham offspring study. Atherosclerosis. 1978;30:17–25. doi: 10.1016/0021-9150(78)90149-1. [DOI] [PubMed] [Google Scholar]
  • 45.Hopkins MH, Fedirko V, Jones DP, Terry PD, Bostick RM. Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: Results from a randomized, controlled clinical trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010;19:850–858. doi: 10.1158/1055-9965.EPI-09-1052. [DOI] [PubMed] [Google Scholar]
  • 46.Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. The New England journal of medicine. 2001;344:549–555. doi: 10.1056/NEJM200102223440802. [DOI] [PubMed] [Google Scholar]
  • 47.Kong SY, Bostick RM, Flanders WD, McClellan WM, Thyagarajan B, Gross MD, et al. Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014;23:545–554. doi: 10.1158/1055-9965.EPI-13-0619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kristal AR, Peters U, Potter JD. Is it time to abandon the food frequency questionnaire? Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14:2826–2828. doi: 10.1158/1055-9965.EPI-12-ED1. [DOI] [PubMed] [Google Scholar]
  • 49.Sies H. Oxidative stress: A concept in redox biology and medicine. Redox biology. 2015;4:180–183. doi: 10.1016/j.redox.2015.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Veglia F, Werba JP, Tremoli E, Squellerio I, Sisillo E, Parolari A, et al. Assessment of oxidative stress in coronary artery bypass surgery: Comparison between the global index oxy-score and individual biomarkers. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2009;14:465–472. doi: 10.3109/13547500903134395. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

RESOURCES